CSS
LEGN icon

Cubist Systematic Strategies’s Legend Biotech LEGN Stock Holding History

Cubist Systematic Strategies’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-7,321
Closed -$357K – 3302
2024
Q3 		$357K Sell
7,321
-51,842
-88% -$2.76M ﹤0.01% 2350
2024
Q2 		$2.62M Buy
+59,163
New +$2.73M 0.02% 1158
2024
Q1 		– Sell
-4,960
Closed -$298K – 4036
2023
Q4 		$298K Buy
4,960
+850
+21% +$53.9K ﹤0.01% 2795
2023
Q3 		$276K Sell
4,110
-137,230
-97% -$9.53M ﹤0.01% 2636
2023
Q2 		$9.76M Buy
+141,340
New +$9.24M 0.06% 444
2023
Q1 		– Sell
-63,387
Closed -$3.16M – 4193
2022
Q4 		$3.16M Buy
63,387
+52,687
+492% +$2.55M 0.02% 1433
2022
Q3 		$437K Sell
10,700
-69,009
-87% -$3.24M ﹤0.01% 3269
2022
Q2 		$4.38M Buy
79,709
+27,579
+53% +$1.16M 0.03% 1111
2022
Q1 		$1.89M Buy
52,130
+21,530
+70% +$851K 0.02% 1525
2021
Q4 		$1.43M Sell
30,600
-24,583
-45% -$1.25M 0.01% 1644
2021
Q3 		$2.79M Sell
55,183
-32,275
-37% -$1.34M 0.04% 798
2021
Q2 		$3.59M Buy
+87,458
New +$2.97M 0.04% 736
2021
Q1 		– Sell
-9,639
Closed -$271K – 2906
2020
Q4 		$271K Buy
9,639
+1,486
+18% +$42.8K ﹤0.01% 2088
2020
Q3 		$252K Buy
8,153
+7,974
+4,455% +$268K ﹤0.01% 2042
2020
Q2 		$8K Buy
+179
New +$6.99K ﹤0.01% 2346

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Cubist Systematic Strategies's LEGN Position: Q4 2024 in Review

Cubist Systematic Strategies sold out of Legend Biotech (LEGN) in Q4 2024, closing a stake of 7,321 shares — an estimated $357K sold.

Cubist Systematic Strategies first reported a position in LEGN in Q2 2020 and held it in 15 quarters. The position peaked at $9.76M in Q2 2023. 211 funds tracked by Wall St. Rank hold LEGN as of Q4 2024.

  • Cubist Systematic Strategies reported no remaining Legend Biotech position as of Q4 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 7,321 Legend Biotech shares in Q4 2024, an estimated $357K.
  • Cubist Systematic Strategies first reported a position in Legend Biotech in Q2 2020 and held it in 15 quarters.
  • Cubist Systematic Strategies's Legend Biotech position peaked at $9.76M in Q2 2023.
  • 211 funds tracked by Wall St. Rank held Legend Biotech as of Q4 2024.

Based on Cubist Systematic Strategies's 13F filing for Q4 2024, filed 14 Feb 2025.